supporting information derivatives synthesis addition of ... · general procedure for catalytic...

73
1 Supporting Information A Chiral-at-Metal Asymmetric Catalyzed Vinylogous Michael Addition of Ortho-Methyl Aromatic Nitro Compounds for Isoxazole Derivatives Synthesis Shi-Wu Li, †,‡ Yu Du* ,† and Qiang Kang* ,† Key Laboratory of Coal to Ethylene Glycol and Its Related Technology, Center for Excellence in Molecular Synthesis, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, 155 Yangqiao Road West, Fuzhou, 350002, P. R. China University of Chinese Academy of Sciences, Beijing, 100049, P. R. China Electronic Supplementary Material (ESI) for Organic Chemistry Frontiers. This journal is © the Partner Organisations 2019

Upload: others

Post on 08-May-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

1

Supporting Information

A Chiral-at-Metal Asymmetric Catalyzed Vinylogous Michael

Addition of Ortho-Methyl Aromatic Nitro Compounds for Isoxazole

Derivatives Synthesis

Shi-Wu Li,†,‡ Yu Du*,† and Qiang Kang*,†

† Key Laboratory of Coal to Ethylene Glycol and Its Related Technology, Center for

Excellence in Molecular Synthesis, Fujian Institute of Research on the Structure of

Matter, Chinese Academy of Sciences, 155 Yangqiao Road West, Fuzhou, 350002, P.

R. China

‡ University of Chinese Academy of Sciences, Beijing, 100049, P. R. China

Electronic Supplementary Material (ESI) for Organic Chemistry Frontiers.This journal is © the Partner Organisations 2019

Page 2: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

2

Table of Contents

I General Information ....................................................................3

II Optimization of Reaction Conditions .........................................4

III Experimental Section ...................................................................6

IV References ...................................................................................20

V NMR Spectrum...........................................................................21

VI Chiral HPLC trace analysis……………………………………47

VII Single Crystal X-Ray Diffraction of 4f .....................................72

Page 3: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

3

I General Information

All reactions were performed in Schlenk tubes at 30 oC using oven-dried glassware.

Commercially obtained reagents were used without further purification, unless

otherwise noted. Dry 1,2-dichloroethane (DCE) was obtained from solvent distillation

machine (Vigor VSPS-5) and stored under argon over 4 Å type molecular sieves. THF

and toluene were distilled freshly before use over sodium and benzophenone.

Dichloromethane (DCM) was distilled from CaH2. Methanol was used without further

purification. Reactions were checked by TLC analysis and plates were visualized with

short-wave UV light (254 nm). The 1H and 13C NMR spectra were obtained in CDCl3

using a Bruker-BioSpin AVANCE III HD NMR spectrometer at 400 and 100 MHz,

respectively. Chemical shifts are reported in parts per million (δ value) calibrated

against the residual solvent peak. Signal patterns are indicated as follows: s, singlet; d,

doublet; t, triplet; q, quartet; m, multiplet. Coupling constants (J) are given in hertz

(Hz). HPLC analyses of the compounds were performed on chiralcel IA-IF columns

and chiralcel AD-H, AS-H, OJ-H and OD-H columns using hexane and isopropanol

as eluent. The infrared spectra were recorded on a Bruker VERTEX 70 IR

spectrometer as KBr pellets, with absorption reported in cm-1. High-resolution mass

spectra were recorded on a Bruker Impact II UHR TOF LC/MS Mass Spectrometry.

Page 4: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

4

II Optimization of Reaction Conditions

Table 1. Optimization of the reaction conditionsa

ON

O2N

Me

MeO

N

N

Me

+O N

NO2

MeO

N

N

Me1a 2a 3a

(2 mol %)

base (0.2 eq-10 eq)

10 h-120 hsolvent, 30 oC

Ar1 =

Me

Me

Ar2 =

CF3

CF3

amine:

M

N

O

N

OtBu

tBu

N

N

+ PF6-

-M

R1

R1

R1 R2

-Rh1-Rh2-Rh3-Ir1

R2

R2

H

H

H

H

H

Ar1

Ar2

HCCH3

C CH3

Rh, Ir

N

DIPEA

N

TEA

N

N

DBUN

N

DABCO

entry Ʌ-M (x mol %) base (y equiv.) solvent time (h) yield (%)b ee(%)c

1 Ʌ-Rh1 (2) DIPEA (0.2) DCE 96 95 94

2 Ʌ-Rh2 (2) DIPEA (0.2) DCE 96 90 94

3 Ʌ-Rh3 (2) DIPEA (0.2) DCE 96 92 79

4 Ʌ-Ir1 (2) DIPEA (0.2) DCE 120 70 92

5 / DIPEA (0.2) DCE 24 NR NR

6 Ʌ-Rh1 (2) / DCE 24 trace trace

7 Ʌ-Rh1 (2) DIPEA (0.2) DCM 96 75 93

8 Ʌ-Rh1 (2) DIPEA (0.2) THF 96 86 90

9 Ʌ-Rh1(2) DIPEA (0.2) CH3OH 96 95 88

10 Ʌ-Rh1(2) DIPEA (0.2) toluene 96 85 78

11 Ʌ-Rh1(2) DABCO (0.2) DCE 96 68 93

12 Ʌ-Rh1(2) DBU (0.2) DCE 96 80 92

13 Ʌ-Rh1(2) TEA (0.2) DCE 96 90 94

15 d Ʌ-Rh1(2) DIPEA (0.2) DCE 40 92 94

16 d Ʌ-Rh1(2) DIPEA (0.5) DCE 18 96 95

Page 5: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

5

17 d Ʌ-Rh1(2) DIPEA (2.0) DCE 16 95 94

18 d Ʌ-Rh1(2) DIPEA (5.0) DCE 14 90 94

19 d Ʌ-Rh1(2) DIPEA (10.0) DCE 10 93 95

20 d Ʌ-Rh1(1) DIPEA (0.5) DCE 60 92 94

aReaction conditions: 1a (0.20 mmol), 2a (0.40 mmol), Ʌ-M (2 mol %), base (0.2 - 10 eq), solvent

(0.5-1 mL) at 30 oC under argon atmosphere. bIsolated yields. cDetermined by chiral HPLC. d1,2-

dichloroethane (0.5 mL). DIPEA = N,N-Diisopropylethylamine, DABCO = Triethylenediamine, DBU=

1,8-Diazabicyclo[5.4.0]undec-7-ene, TEA= Triethylamine.

Page 6: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

6

III Experimental Section

Ʌ-Rh1, Ʌ-Rh2, Ʌ-Rh3 and Ʌ-Ir1 were prepared according to reported procedure.1-2

α,β-unsaturated 2-acyl imidazoles3 and 3,5-disubstituted-4-nitroisoxazole substrates

2a-2f were synthesized according to reported procedures.4

General procedure for catalytic asymmetric synthesis of isoxazole analogues.

ON

O2N

Me

R2R1

O

N

N

R

+

O N

NO2

R2R1O

N

N

R

-Rh1 (2 mol %)

DIPEA (0.5 eq)DCE, 30 oC18 h-192 h1 2 3

To an oven-dried 25 mL Schlenk tube equipped with a stir bar, Ʌ-Rh1 (2.0 mol %)

was added along with α,β-unsaturated 2-acyl imidazole 1 (1 equiv., 0.2 mmol),

DIPEA (50 mol %) and DCE (0.5 mL). After being stirred at room temperature for 5

min, 3,5-disubstituted-4-nitroisoxazole substrates 2 (2.0 equiv., 0.40 mmol) was

added. The reaction was stirring at 30 oC until consumption of the 2-acyl imidazole

(monitored by TLC). The reaction mixture was concentrated and directly purified by

silica gel column chromatography (with ethyl acetate-petroleum ether as the eluent) to

afford the desired products 3 or 4.

General procedure for gram-scale experiments with lower catalyst loading.

Ph

O

N

N

Me

+

1a1.10 g, 5.12 mmol

Rh1 (0.25 mol %)

DIPEA (50 mol %)DCE, 26 h, 30 oCO

N

O2N

Me

Me

2a1.47 g, 10.38 mmol

O N

NO2

MePhO

N

N

Me3a

1.69 g, 93% yield, 95% ee

To an oven-dried 50 mL Schlenk tube equipped with a stir bar, Ʌ-Rh1 (0.25 mol%)

was added along with α,β-unsaturated 2-acyl imidazole 1a (1.10 g, 5.12 mmol, 1.0

equiv.), DIPEA (50 mol %) and DCE (6 mL). After being stirred at room temperature

for 5 min, 3,5-dimethyl-substituted 4-nitroisoxazole 2a (1.47 g, 10.38 mmol, 2.0

equiv.) was added. The reaction was stirring at room temperature until consumption

of the 2-acyl imidazole as monitored by TLC for 26 h. The reaction mixture was

Page 7: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

7

concentrated and directly purified by silica gel column chromatography

(EtOAc/Petroleum ether = 1:4-1:3) to afford 3a (white solid, 1.69 g, 93% yield, 95%

ee).

General procedure for synthetic transformation.

O N

NO2

MePhO

N

N

Me

O N

NO2

MePhO

MeO

3a120 mg, 95% ee

5a86% yield, 95 % ee

(1) CH3I (10 eq), DMF, 80 oC

(2) DBU (1.0 eq), DCM, rt

A solution of 3a (120 mg, 0.34 mmol, 1 equiv.) and methyl iodide (10 equiv.) in DMF

(2 ml) was stirred in a sealed tube at 80 °C overnight, after 3a was fully converted to

salt (monitored by TLC), the reaction was cooled down to room temperature. The

reaction mixture was concentrated and CH3OH (2 mL) was added to the mixture, and

then DBU (10 equiv.) was added to the solution. The resulting mixture was stirred for

12 hours at room temperature before it was quenched with NH4Cl (20 mL, sat. aq.),

the aqueous layer was extracted with EtOAc (3 × 20 mL). The combined organic

layers were washed with brine (20 mL), dried (Na2SO4) and concentrated in vacuo.

Flash column chromatography (silica gel) afforded the desired product 5a (89 mg, 86%

yield, 95% ee).

O N

NO2

MePhO

N

N

Me3a

120 mg, 95% ee6a

93% yield, 90% ee

(1) NaOH (10 eq), THF, H2O

(2) SOCl2 (10 eq), CH3OH60 oC, overnight

COOMePhO

N

N

Me

To the compound 3a (120 mg, 0.34 mmol, 1 equiv.) in 5 mL solvent (5:1 THF/H2O)

was added NaOH (10 equiv.) at 0 oC. The resulting mixture was refluxed for 3 h. The

reaction mixture was quenched with 4 M aqueous HCl and the solvent was removed

under reduced pressure. The remaining precipitation dissolves in methanol, and then 5

mL SOCl2 was added to the above reaction solution. The reaction was stirred at 60 oC

overnight. After evaporation of solvent, dissolved the crude product in 20 mL

Page 8: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

8

saturated sodium carbonate solution and 30 mL ethyl acetate, then the reaction was

stirred under the room temperature for 120 min. The aqueous layer was extracted

three times with ethyl acetate (20 mL × 3). The combined organic layer was dried

over Na2SO4. The volatile solvent was removed under reduced pressure at last, the

product 6a was obtained after purified by flash column chromatography on silica gel

(90 mg, 93% yield, 90% ee) as light yellow oil.

Page 9: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

9

O N

NO2

MeO

N

N

Me 3a

White solid, m.p. 119.1-119.5 oC, 68 mg, 96% yield, 95% ee (HPLC: chiralpak IC

column, 254 nm, hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 9.50

min, tr (minor) = 10.88 min); [α]D25 = +16.8 (c = 0.5, CHCl3). 1H NMR (400 MHz,

CDCl3): δ = 7.26 (d, J = 4.3 Hz, 4H), 7.20-7.18 (m, 1H), 7.13 (s, 1H), 7.01 (s, 1H),

4.01-3.92 (m, 1H), 3.91 (s, 3H), 3.74-3.62 (m, 2H), 3.58-3.50 (m, 2H), 2.47 (s, 3H).

13C NMR (CDCl3, 100 MHz): δ = 189.9, 173.2, 155.4, 142.8, 141.8, 130.4, 129.2,

128.7, 127.3, 127.2, 44.5, 38.9, 36.2, 34.2, 11.7. IR (KBr): ν (cm-1) 2921, 2851, 2359,

1676, 1603, 1519, 1415, 1379, 1365, 1289, 1075, 985, 915, 829. HRMS (ESI, m/z)

calcd for C18H18N4NaO4 [M+Na]+: 377.1219, found: 377.1220.

O N

NO2

MeO

N

N

Me

Br

3b

Light yellow oil, 79 mg, 92% yield, 97% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 9.74 min, tr (minor) =

10.93 min); [α]D25 = +8.4 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.51 (d,

J = 8.0 Hz, 1H), 7.34 (d, J = 7.7 Hz, 1H), 7.26 (d, J = 7.8 Hz, 1H), 7.13 (s, 1H), 7.13-

7.03 (m, 1H), 7.03 (s, 1H), 4.58-4.51 (m, 1H), 3.94 (s, 3H), 3.68-3.56 (m, 4H), 2.49 (s,

3H). 13C NMR (CDCl3, 100 MHz): δ = 189.4, 172.5, 155.4, 142.7, 140.7, 133.3,

130.6, 129.2, 128.7, 127.9, 127.3, 124.5, 43.6, 37.4, 36.2, 32.8, 11.7. IR (KBr): ν (cm-

1) 2922, 2852, 2361, 1675, 1603, 1519, 1413, 1379, 1365, 1289, 1155, 1023, 985, 829,

759. HRMS (ESI, m/z) calcd for C18H17BrN4NaO4 [M+Na]+: 455.0324, found:

455.0325.

O N

NO2

MeO

N

N

Me

Br

3c

Yellow oil, 75 mg, 87% yield, 95% ee (HPLC: chiralpak IC column, 254 nm,

Page 10: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

10

hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 8.21 min, tr (minor) =

8.93 min); [α]D25 = +12.4 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.42 (s,

1H), 7.33 (d, J = 7.9 Hz, 1H), 7.22 (d, J = 7.7 Hz, 1H), 7.20-7.10 (m, 1H), 7.14 (s,

1H), 7.04 (s, 1H), 4.00-3.95 (m, 1H), 3.93 (s, 3H), 3.71-3.50 (m, 4H), 2.49 (s, 3H).

13C NMR (CDCl3, 100 MHz): δ = 189.3, 172.6, 155.5, 144.2, 142.5, 130.5, 130.4,

130.3, 129.2, 127.4, 126.0, 122.7, 44.3, 38.5, 36.2, 34.0, 11.6. IR (KBr): ν (cm-1) 2923,

2360, 1676, 1615, 1519, 1413, 1383, 1289, 984. HRMS (ESI, m/z) calcd for

C18H17BrN4NaO4 [M+Na]+: 455.0325, found: 455.0325.

O N

NO2

MeO

N

N

Me

Br

3d

Light yellow oil, 77 mg, 89% yield, 96% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 8.58 min, tr (minor) =

9.40 min); [α]D25 = +15.9 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.38 (d,

J = 8.4 Hz, 2H), 7.16 (d, J = 8.4 Hz, 2H), 7.13 (s, 1H), 7.03 (s, 1H), 4.01-3.96(m, 1H),

3.92 (s, 3H), 3.73-3.60 (m, 2H), 3.53-3.46 (m, 2H), 2.49 (s, 3H). 13C NMR (CDCl3,

100 MHz): δ = 189.5, 172.7, 155.5, 142.7, 140.8, 131.8, 130.4, 129.3, 129.1, 127.4,

121.1, 44.3, 38.3, 36.2, 34.0, 11.7. IR (KBr): ν (cm-1) 2922, 2360, 1674, 1603, 1519,

1414, 1382, 1289, 985, 828. HRMS (ESI, m/z) calcd for C18H17BrN4NaO4 [M+Na]+:

455.0322, found: 455.0325.

O N

NO2

MeO

N

N

Me

Cl

3e

Light yellow oil, 74 mg, 95% yield, 96% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 8.24 min, tr (minor) =

9.05 min); [α]D25 = +12.1 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.22 (brs,

Page 11: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

11

4H), 7.13 (s, 1H), 7.03 (s, 1H), 4.03-3.95(m, 1H), 3.92 (s, 3H), 3.73-3.60 (m, 2H),

3.54-3.47 (m, 2H), 2.49 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ = 189.5, 172.8, 155.5,

142.7, 140.3, 132.9, 130.4, 129.3, 128.9, 128.7, 127.4, 44.4, 38.3, 36.2, 34.1, 11.7. IR

(KBr): ν (cm-1) 2922, 2360, 2340, 1674, 1603, 1519, 1492, 1415, 1380, 1092, 829.

HRMS (ESI, m/z) calcd for C18H17ClN4NaO4 [M+Na]+: 411.0841, found: 411.0831.

O N

NO2

MeO

N

N

Me

CN

3f

Light yellow oil, 68 mg, 90% yield, 92% ee (HPLC: chiralpak OD-H column, 254 nm,

hexane/isopropanol = 70/30, flow rate 1.0 mL/min, tr (major) = 14.08 min, tr (minor)

= 16.97 min); [α]D25 = +7.8 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.57

(d, J = 8.1 Hz, 2H), 7.42 (d, J = 8.1 Hz, 2H), 7.15 (s, 1H), 7.06 (s, 1H), 4.10-4.00 (m,

1H), 3.93 (s, 3H), 3.79-3.73 (m, 1H), 3.69-3.63 (m, 1H), 3.58-3.52 (m, 2H), 2.49 (s,

3H). 13C NMR (CDCl3, 100 MHz): δ = 188.9, 172.2, 155.6, 147.3, 142.3, 132.6,

130.5, 129.2, 128.3, 127.6, 118.6, 111.3, 44.1, 38.8, 36.2, 33.7, 11.6. IR (KBr): ν (cm-

1) 2922, 2360, 1672, 1603, 1593, 1517, 1409, 1385, 1366, 702. HRMS (ESI, m/z)

calcd for C19H17N5NaO4 [M+Na]+: 402.1170, found: 402.1173.

O N

NO2

MeO

N

N

Me

OMe

3g

Light yellow oil, 65 mg, 85% yield, 94% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 13.38 min, tr (minor)

= 15.38 min); [α]D25 = +18.0 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.18

(d, J = 8.5 Hz, 2H), 7.12 (s, 1H), 7.01 (s, 1H), 6.78 (d, J = 8.5 Hz, 2H), 3.99-3.95 (m,

1H), 3.91 (s, 3H), 3.74 (s, 3H), 3.71-3.59 (m, 2H), 3.53-3.46 (m, 2H), 2.47 (s, 3H).

13C NMR (CDCl3, 100 MHz): δ = 190.0, 173.3, 158.5, 155.4, 142.8, 133.8, 130.4,

Page 12: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

12

129.2, 128.3, 127.2, 114.0, 55.2, 44.7, 38.2, 36.1, 34.4, 11.7. IR (KBr): ν (cm-1) 2923,

2360, 2341, 1672, 1604, 1514, 1410, 1382, 1249, 985, 829. HRMS (ESI, m/z) calcd

for C19H20N4NaO5 [M+Na]+: 407.1326, found: 407.1326.

O N

NO2

MeO

N

N

Me

Me

3h

Light yellow oil, 66 mg, 90% yield, 94% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 9.90 min, tr (minor) =

10.99 min); [α]D25 = +14.3 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.15 (d,

J = 7.9 Hz, 2H), 7.12 (s, 1H), 7.06 (d, J = 7.9 Hz, 2H), 7.01 (s, 1H), 3.98-3.94 (m, 1H),

3.91 (s, 3H), 3.71-3.59 (m, 2H), 3.56-3.47 (m, 2H), 2.47 (s, 3H), 2.27 (s, 3H). 13C

NMR (CDCl3, 100 MHz): δ = 190.0, 173.3, 155.4, 142.8, 138.8, 136.8, 130.4, 129.4,

129.2, 127.2, 127.1, 44.6, 38.5, 36.2, 34.3, 21.1, 11.7. IR (KBr): ν (cm-1) 2922, 2360,

2341, 1673, 1603, 1518, 1492, 1410, 1379, 1365, 985, 829. HRMS (ESI, m/z) calcd

for C19H20N4NaO4 [M+Na]+: 391.1376, found: 391.1377.

O N

NO2

MeO

N

N

Me 3i

White solid, 75 mg, m.p. 130.1-130.5 oC, 93% yield, 96% ee (HPLC: chiralpak IC

column, 254 nm, hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 9.98

min, tr (minor) = 10.92 min); [α]D25 = +13.2 (c = 0.5, CHCl3). 1H NMR (400 MHz,

CDCl3): δ = 8.24 (d, J = 8.5 Hz, 1H), 7.83 (d, J = 8.0 Hz, 1H), 7.72 (d, J = 8.1 Hz,

1H), 7.56-7.39 (m, 4H), 7.13 (s, 1H), 6.99 (s, 1H), 4.98 (brs, 1H), 3.85 (s, 3H), 3.83-

3.60 (m, 4H), 2.41 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ = 190.0, 173.0, 155.4,

142.7, 138.1, 133.9, 131.1, 130.5, 129.3, 129.0, 127.8, 127.3, 126.5, 125.7, 125.5,

123.5, 122.6, 44.5, 36.1, 33.7, 32.8, 11.6. IR (KBr): ν (cm-1) 2921, 2851, 2361, 2341,

Page 13: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

13

1672, 1601, 1518, 1409, 1155, 829, 778. HRMS (ESI, m/z) calcd for C22H20N4NaO4

[M+Na]+: 427.1377, found: 427.1377.

O N

NO2

MeO

N

N

Me

S

3j

Light yellow oil, 66 mg, 91% yield, 95% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 11.20 min, tr (minor)

= 12.22 min); [α]D25 = +16.7 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.18-

7.11 (m, 1H), 7.13 (s, 1H), 7.04 (s, 1H), 6.86 (t, J = 3.5 Hz, 2H), 4.37-4.30 (m, 1H),

3.95 (s, 3H), 3.77-3.65 (m, 2H), 3.60-3.54 (m, 2H), 2.50 (s, 3H). 13C NMR (CDCl3,

100 MHz): δ = 189.3, 172.6, 155.5, 145.2, 142.6, 130.6, 129.3, 127.4, 126.8, 124.5,

124.1, 45.4, 36.2, 35.1, 34.2, 11.7. IR (KBr): ν (cm-1) 2361, 2341, 1675, 1603, 1519,

1414, 1378, 981, 915, 829, 703. HRMS (ESI, m/z) calcd for C16H16N4NaO4S

[M+Na]+: 383.0785, found: 383.0784.

O N

NO2

MeO

N

N

Me

O

3k

Light yellow oil, 60 mg, 87% yield, 93% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 87/13, flow rate 1.0 mL/min, tr (major) = 16.37 min, tr (minor)

= 17.80 min); [α]D25 = +27.6 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.29

(s, 1H), 7.14 (s, 1H), 7.05 (s, 1H), 6.22 (m, 1H), 6.06 (d, J = 3.2 Hz, 1H), 4.14-4.06

(m, 1H), 3.97 (s, 3H), 3.73-3.64 (m, 2H), 3.58-3.47 (m, 2H), 2.52 (s, 3H). 13C NMR

(CDCl3, 100 MHz): δ = 189.4, 172.7, 155.5, 154.6, 142.6, 141.9, 130.5, 129.3, 127.3,

110.2, 106.0, 42.1, 36.2, 32.5, 31.9, 11.7. IR (KBr): ν (cm-1) 2922, 2361, 2341, 1675,

1604, 1519, 1415, 1380, 1151, 915, 830. HRMS (ESI, m/z) calcd for C16H16N4NaO5

[M+Na]+: 367.1013, found: 367.1013.

O N

NO2

MeO

N

N

Me

Me

3l

Page 14: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

14

Light yellow oil, 47 mg, 80% yield, 94% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 94/6, flow rate 1.0 mL/min, tr (major) = 21.72 min, tr (minor) =

23.38 min); [α]D25 = +9.2 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.13 (s,

1H), 7.05 (s, 1H), 4.00 (s, 3H), 3.32-3.12 (m, 4H), 2.84-2.76 (m, 1H), 2.55 (s, 3H),

1.10 (d, J = 6.8 Hz, 3H). 13C NMR (CDCl3, 100 MHz): δ = 191.0, 174.0, 155.6, 142.9,

130.4, 129.0, 127.2, 45.2, 36.3, 33.9, 28.6, 20.3, 11.7. IR (KBr): ν (cm-1) 2360, 2341,

1690, 1609, 1521, 1418, 1382, 1169, 829. HRMS (ESI, m/z) calcd for C13H16N4NaO4

[M+Na]+: 315.1062, found: 315.1064.

O N

NO2

MeO

N

N

Me

COOEt

3m

Light yellow oil, 62 mg, 89% yield, 93% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 75/25, flow rate 1.0 mL/min, tr (major) = 17.74 min, tr (minor)

= 22.34 min); [α]D25 = +5.6 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.08 (s,

1H), 6.99 (s, 1H), 4.08 (q, J = 7.1 Hz, 2H), 3.92 (s, 3H), 3.68-3.58(m, 2H), 3.53-3.35

(m, 3H), 2.49 (s, 3H), 1.13 (t, J = 7.1 Hz, 3H). 13C NMR (CDCl3, 100 MHz): δ =

188.0, 171.6, 171.5, 154.6, 141.2, 129.4, 128.2, 126.3, 60.4, 39.0, 36.8, 35.2, 28.1,

12.9, 10.6. IR (KBr): ν (cm-1) 2921, 2360, 2341, 1734, 1679, 1607, 1520, 1417, 1383,

1155, 829. HRMS (ESI, m/z) calcd for C15H18N4NaO6 [M+Na]+: 373.1120, found:

373.1119.

O N

NO2

MeCF3O

N

N

Ph3n

Light yellow oil, 68 mg, 83% yield, 97% ee (HPLC: chiralpak AD-H column, 254 nm,

hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 11.74 min, tr (minor)

= 9.50 min); [α]D25 = -15.0 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.49-

7.43 (m, 3H), 7.29-7.18 (m, 4H), 3.68-3.58 (m, 2H), 3.54-3.45 (m, 2H), 3.28 (dd, J =

14.8, 7.2 Hz, 1H), 2.50 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ = 185.8, 170.8, 155.7,

141.9, 137.9, 130.7, 130.1, 129.1, 129.0, 127.9, 126.8 (q, J = 279.7 Hz), 125.9, 37.4,

36.6 (q, J = 27.8 Hz), 26.6 (q, J = 2.8 Hz), 11.6. 19F NMR (376.4 MHz, CDCl3): δ = -

Page 15: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

15

71.7. IR (KBr): ν (cm-1) 2360, 2341, 1690, 1608, 1521, 1418, 1382, 1168, 829.

HRMS (ESI, m/z) calcd for C18H15F3N4NaO4 [M+Na]+: 431.0936, found: 431.0938.

O N

NO2

MeO

N

N

i-Pr 3o

Light yellow oil, 73 mg, 95% yield, 92% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 9.19 min, tr (minor) =

8.30 min); [α]D25 = -17.2 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.27-

7.23 (m, 5H), 7.20-7.14 (m, 2H), 5.46-5.36 (m, 1H), 4.04-3.96 (m, 1H), 3.74-3.50 (m,

4H), 2.47 (s, 3H), 1.38 (d, J = 6.6 Hz, 3H), 1.35 (d, J = 6.6 Hz, 3H). 13C NMR (CDCl3,

100 MHz): δ = 190.1, 173.2, 155.4, 142.0, 141.8, 130.4, 129.7, 128.7, 127.3, 127.2,

121.4, 49.2, 45.1, 39.0, 34.3, 23.6, 23.4, 11.6. IR (KBr): ν (cm-1) 2361, 2341, 1674,

1603, 1519, 1396, 1381, 1365, 1255, 985, 829. HRMS (ESI, m/z) calcd for

C20H22N4NaO4 [M+Na]+: 405.1531, found: 405.1533.

O N

NO2

MeO

N

N

Ph 3p

Light yellow oil, 75 mg, 90% yield, 95% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 11.63 min, tr (minor)

= 14.78 min); [α]D25 = -31.3 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.43-

7.38 (m, 3H), 7.26-7.11 (m, 9H), 3.98-3.91 (m, 1H), 3.74-3.54 (m, 3H), 3.50-3.44 (m,

1H), 2.45 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ = 188.5, 173.1, 155.4, 142.7, 141.8,

138.1, 130.4, 129.7, 129.0, 128.8, 128.7, 127.4, 127.3, 125.8, 44.7, 38.8, 34.2, 11.7.

IR (KBr): ν (cm-1) 2923, 2360, 2341, 1685, 1602, 1517, 1493, 1407, 1378, 1364, 829,

763, 700. HRMS (ESI, m/z) calcd for C23H20N4NaO4 [M+Na]+: 439.1375, found:

439.1377.

Page 16: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

16

O N

NO2

O

N

N

Me4a

Light yellow oil, 73 mg, 88% yield, 90% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 9.39 min, tr (minor) =

10.57 min); [α]D25 = +18.7 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.53-

7.44 (m, 5H),7.31-7.18 (m, 5H), 7.14 (s, 1H), 7.01 (s, 1H), 4.10-4.03 (m, 1H), 3.91 (s,

3H), 3.78-3.57 (m, 4H). 13C NMR (CDCl3, 100 MHz): δ = 189.9, 173.8, 157.6, 142.8,

141.8, 130.7, 129.8, 129.2, 128.8, 128.5, 127.3, 125.8, 44.4, 38.9, 36.2, 34.5. IR

(KBr): ν (cm-1) 2922, 2851, 2360, 2341, 1676, 1636, 1617, 1593, 1515, 1413, 1367,

829. HRMS (ESI, m/z) calcd for C23H20N4NaO4 [M+Na]+: 439.1375, found: 439.1377.

O N

NO2

O

N

N

Me

F

4b

Light yellow oil, 78 mg, 90% yield, 95% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 8.45 min, tr (minor) =

9.30 min); [α]D25 = +7.9 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.55-7.51

(m, 2H), 7.31-7.26 (m, 4H), 7.21-7.12 (m, 4H), 7.01 (s, 1H), 4.09-4.02 (m, 1H), 3.90

(s, 3H), 3.78-3.57 (m, 4H). 13C NMR (CDCl3, 100 MHz): δ = 189.8, 174.1, 164.2 (d,

J = 249.9 Hz), 156.7, 142.7, 141.8, 131.5 (d, J = 8.7 Hz), 129.7, 129.2, 128.8, 127.3,

127.3, 121.9 (d, J = 3.5 Hz), 115.7 (d, J = 21.9 Hz), 44.5, 38.9, 36.2, 34.5. 19F NMR

(376.4 MHz, CDCl3): δ = -109.2. IR (KBr): ν (cm-1) 2922, 2360, 2341, 1674, 1606,

1617, 1593, 1515, 1413, 1367, 828, 699. HRMS (ESI, m/z) calcd for C23H19FN4NaO4

[M+Na]+: 457.1283, found: 457.1283.

O N

NO2

O

N

N

Me

Cl

4c

White solid, 83 mg, m.p. 128.4-128.8 oC, 92% yield, 95% ee (HPLC: chiralpak IC

column, 254 nm, hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 8.83

Page 17: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

17

min, tr (minor) = 9.69 min); [α]D25 = +8.0 (c = 0.5, CHCl3). 1H NMR (400 MHz,

CDCl3): δ = 7.48-7.41 (m, 4H), 7.31-7.25 (m, 4H), 7.21-7.18 (m, 1H), 7.13 (s, 1H),

7.01 (s, 1H), 4.10-4.02 (m, 1H), 3.90 (s, 3H), 3.77-3.57 (m, 4H). 13C NMR (CDCl3,

100 MHz): δ = 189.8, 174.2, 156.7, 142.7, 141.7, 137.0, 130.7, 129.7, 129.2, 128.8,

127.6, 127.4, 127.3, 124.3, 44.5, 38.9, 36.2, 34.5. IR (KBr): ν (cm-1) 2918, 2849, 2360,

2341, 1671, 1604, 1521, 1507, 1409, 1384, 831, 701. HRMS (ESI, m/z) calcd for

C23H19ClN4NaO4 [M+Na]+: 473.0983, found: 473.0987.

O N

NO2

O

N

N

Me

OMe

4d

White solid, 85 mg, m.p. 126.5-126.9 oC, 95% yield, 95% ee (HPLC: chiralpak IC

column, 254 nm, hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) =

13.60 min, tr (minor) = 15.61 min); [α]D25 = +9.1 (c = 0.5, CHCl3). 1H NMR (400

MHz, CDCl3): δ = 7.49 (d, J = 8.7 Hz, 2H), 7.31-7.25 (m, 4H), 7.20 (t, J = 7.0 Hz,

1H), 7.13 (s, 1H), 7.00 (s, 1H), 6.96 (d, J = 8.7 Hz, 2H), 4.09-4.02 (m, 1H), 3.90 (s,

3H), 3.84 (s, 3H), 3.77-3.55 (m, 4H). 13C NMR (CDCl3, 100 MHz): δ = 189.9, 173.8,

161.5, 157.2, 142.7, 141.9, 130.8, 129.8, 129.2, 128.8, 127.4, 127.3, 117.9, 113.9,

55.4, 44.4, 38.9, 36.2, 34.5. IR (KBr): ν (cm-1) 2924, 2360, 1674, 1598, 1520, 1411,

1365, 1155, 982, 827, 702. HRMS (ESI, m/z) calcd for C24H22N4NaO5 [M+Na]+:

469.1479, found: 469.1482.

O N

NO2

O

N

N

Me

Me

4e

Yellow oil, 77 mg, 90% yield, 95% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) = 8.88 min, tr (minor) =

10.15 min); [α]D25 = +4.8 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.36-

7.25 (m, 8H), 7.20 (t, J = 6.8 Hz, 1H), 7.13 (s, 1H), 7.00 (s, 1H), 4.10-4.02 (m, 1H),

3.90 (s, 3H), 3.78-3.55 (m, 4H), 2.40 (s, 3H). 13C NMR (CDCl3, 100 MHz): δ = 189.9,

173.7, 157.7, 142.8, 141.8, 138.3, 131.4, 129.8, 129.7, 129.2, 128.8, 128.4, 127.3,

Page 18: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

18

126.3, 125.7, 44.4, 38.9, 36.2, 34.5, 21.4. IR (KBr): ν (cm-1) 2924, 2360, 1674, 1598,

1520, 1411, 1365, 1155, 982, 702. HRMS (ESI, m/z) calcd for C24H22N4NaO4

[M+Na]+: 453.1532, found: 453.1533.

O N

NO2

O

N

N

Me

S

4f

White solid, 75 mg, m.p. 120.2-120.5 oC, 89% yield, 95% ee (HPLC: chiralpak IC

column, 254 nm, hexane/isopropanol = 80/20, flow rate 1.0 mL/min, tr (major) =

10.75 min, tr (minor) = 11.80 min); [α]D25 = +13.0 (c = 0.5, CHCl3). 1H NMR (400

MHz, CDCl3): δ = 7.80 (t, J = 3.1 Hz, 1H), 7.53-7.51 (m, 1H), 7.31-7.25 (m, 4H),

7.21-7.12 (m, 3H), 7.00 (s, 1H), 4.08-4.01 (m, 1H), 3.89 (s, 3H), 3.75-3.55 (m, 4H).

13C NMR (CDCl3, 100 MHz): δ = 189.9, 174.5, 151.7, 142.7, 141.8, 131.8, 129.9,

129.4, 129.2, 128.8, 127.8, 127.3, 127.2, 125.6, 44.5, 38.9, 36.2, 34.6. IR (KBr): ν

(cm-1) 2922, 2360, 1673, 1594, 1517, 1409, 1385, 1365, 702. HRMS (ESI, m/z) calcd

for C21H18N4NaO4S [M+Na]+: 445.0943, found: 445.0941.

O N

NO2

O

MeOMe

5a

Light yellow oil, 88.6 mg, 86% yield, 95% ee (HPLC: chiralpak OD-H column, 254

nm, hexane/isopropanol = 90/10, flow rate 1.0 mL/min, tr (major) = 9.88 min, tr

(minor) = 15.62 min); [α]D25 = +5.6 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ

= 7.28 (t, J = 6.9 Hz, 2H), 7.23-7.19 (m, 3H), 3.82-3.74 (m, 1H), 3.65-3.59 (m, 1H),

3.60 (s, 3H), 3.55-3.49 (m, 1H), 2.82-2.72 (m, 2H), 2.48 (s, 3H). 13C NMR (CDCl3,

100 MHz): δ = 172.8, 171.6, 155.5, 141.1, 130.4, 128.9, 127.5, 127.0, 51.9, 40.3, 39.9,

33.8, 11.6. IR (KBr): ν (cm-1) 2921, 2360, 1733, 1679, 1607, 1520, 1416, 1384, 1155,

829. HRMS (ESI, m/z) calcd for C15H16N2NaO5 [M+Na]+: 327.0949, found: 327.0951.

Page 19: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

19

6a

COOMeO

N

N

Me

Light yellow oil, 90.0 mg, 93% yield, 90% ee (HPLC: chiralpak IC column, 254 nm,

hexane/isopropanol = 85/15, flow rate 1.0 mL/min, tr (major) = 11.68 min, tr (minor)

= 13.53 min); [α]D25 = +12.3 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.30-

7.22 (m, 4H), 7.19-7.14 (m, 1H), 7.12 (s, 1H), 7.00 (s, 1H), 3.91 (s, 3H), 3.88-3.83 (m,

1H), 3.65 (dd, J = 17.0, 7.7 Hz, 1H), 3.57 (s, 3H), 3.47 (dd, J = 17.0, 6.7 Hz, 1H),

2.77 (dd, J = 15.6, 7.0 Hz, 1H), 2.67 (dd, J = 15.6, 8.0 Hz, 1H). 13C NMR (CDCl3,

100 MHz): δ = 190.4, 172.3, 143.2, 128.7, 128.5, 127.5, 126.9, 126.7, 51.6, 44.8, 41.0,

37.2, 36.2. IR (KBr): ν (cm-1) 2924, 2361 1733, 1679, 1607, 1520, 1416, 1384, 1155,

828. HRMS (ESI, m/z) calcd for C16H18N2NaO3 [M+Na]+: 309.1215, found: 309.1216.

Page 20: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

20

IV References

(1) (a) C. Wang, L.-A. Chen, H. Huo, X. Shen, K. Harms, L. Gong and E. Meggers,

Chem. Sci., 2015, 6, 1094; (b) G.-J. Sun, J. Gong and O. Kang, J. Org. Chem., 2017,

82, 796; (c) S.-W. Li, J. Gong and Q. Kang, Org. Lett., 2017, 19, 1350; (d) K. Li, Q.

Wan and Q. Kang, Org. Lett., 2017, 19, 3299; (e) S.-X. Lin, G.-J. Sun and Q. Kang,

Chem. Commun., 2017, 53, 7665.

(2) H. Huo, X. Shen, C. Wang, L. Zhang, P. Rose, L.-A. Chen, K. Harms, M. Marsch,

G. Hilt and E. Meggers, Nature, 2014, 515, 100.

(3) H. Huo, C. Fu, K. Harms and E. Meggers, J. Am. Chem. Soc., 2014, 136, 2990.

(4) (a) J.-L. Zhang, X.-H. Liu, X.-J. Ma and R. Wang, Chem. Commun., 2013, 49,

9329; (b) G. Fuller, B. Kelly and M. F. A. Adamo, Org. Process Res. Dev., 2015, 19,

1274; (c) C. Balsamini, G. Spadoni, L. Staccioli and E. Duranti, J. Org. Chem., 1988,

53, 2870; (d) S. Chimichi, P. Sarti-Fantoni, A. Buzzi, D. Giomi and R. Nesi,

Heterocycles, 1985, 23, 1465.

Page 21: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

21

V NMR Spectrum1H NMR (400 MHz) spectra of 3a

8 7 6 5 4 3 2 1 0 ppm

2.471

3.500

3.518

3.537

3.554

3.561

3.580

3.621

3.642

3.658

3.679

3.697

3.722

3.739

3.915

3.995

4.014

7.012

7.128

7.175

7.184

7.196

7.204

7.256

7.266

3.000

2.039

2.075

3.030

1.037

1.023

0.939

1.047

4.312

13C NMR (100 MHz) spectra of 3a

200 180 160 140 120 100 80 60 40 20 0 ppm

11.7

34.2

36.2

38.9

44.5

76.7

77.1

77.4

127.2

127.3

128.7

129.2

130.4

141.8

142.8

155.4

173.2

189.9

O N

NO2

MeO

N

N

Me 3a

O N

NO2

MeO

N

N

Me 3a

Page 22: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

22

1H NMR (400 MHz) spectra of 3b

8 7 6 5 4 3 2 1 0 ppm

2.488

3.563

3.584

3.600

3.621

3.629

3.638

3.646

3.656

3.663

3.682

3.941

4.512

4.530

4.548

4.567

4.585

7.033

7.044

7.047

7.064

7.082

7.086

7.129

7.238

7.257

7.277

7.331

7.350

7.497

7.517

3.059

3.959

2.948

0.974

1.981

0.932

1.214

1.013

1.000

13C NMR (100 MHz) spectra of 3b

200 180 160 140 120 100 80 60 40 20 0 ppm

11.7

32.8

36.2

37.4

43.6

76.8

77.1

77.4

124.5

127.3

127.9

128.7

129.2

130.6

133.3

140.7

142.7

155.4

172.5

189.4

O N

NO2

MeO

N

N

Me

Br

3b

O N

NO2

MeO

N

N

Me

Br

3b

Page 23: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

23

1H NMR (400 MHz) spectra of 3c

8 7 6 5 4 3 2 1 0 ppm

2.495

3.496

3.507

3.513

3.525

3.533

3.550

3.568

3.591

3.611

3.628

3.646

3.663

3.688

3.706

3.929

3.945

3.964

3.983

4.001

7.037

7.123

7.137

7.162

7.217

7.236

7.318

7.337

7.423

3.008

4.153

4.021

1.000

1.972

1.029

0.993

1.003

13C NMR (100 MHz) spectra of 3c

200 180 160 140 120 100 80 60 40 20 0 ppm

11.6

34.0

36.2

38.5

44.3

76.8

77.1

77.4

122.7

126.0

127.4

129.2

130.3

130.5

130.5

142.5

144.2

155.5

172.6

189.3

O N

NO2

MeO

N

N

Me

Br

3c

O N

NO2

MeO

N

N

Me

Br

3c

Page 24: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

24

1H NMR (400 MHz) spectra of 3d

8 7 6 5 4 3 2 1 0 ppm

2.488

3.463

3.480

3.497

3.506

3.517

3.523

3.534

3.600

3.621

3.637

3.659

3.670

3.689

3.713

3.732

3.919

3.959

3.978

3.997

4.015

7.027

7.125

7.152

7.173

7.369

7.390

3.000

1.972

2.057

3.914

1.010

2.932

1.910

13C NMR (100 MHz) spectra of 3d

200 180 160 140 120 100 80 60 40 20 0 ppm

34.5

36.2

38.9

44.4

55.4

76.8

77.1

77.4

113.9

117.9

127.3

127.3

128.8

129.2

129.8

130.8

141.9

142.7

157.2

161.5

173.8

189.9

O N

NO2

MeO

N

N

Me

Br

3d

O N

NO2

MeO

N

N

Me

Br

3d

Page 25: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

25

1H NMR (400 MHz) spectra of 3e

8 7 6 5 4 3 2 1 0 ppm

2.486

3.470

3.483

3.500

3.513

3.520

3.531

3.537

3.600

3.622

3.637

3.659

3.671

3.690

3.714

3.733

3.919

3.951

3.969

3.989

4.007

4.025

7.027

7.128

7.221

3.000

1.980

2.091

2.926

1.048

0.981

1.016

3.935

13C NMR (100 MHz) spectra of 3e

200 180 160 140 120 100 80 60 40 20 0 ppm

11.7

34.1

36.2

38.3

44.4

76.8

77.1

77.4

127.4

128.7

128.9

129.3

130.4

132.9

140.3

142.7

155.5

172.8

189.5

O N

NO2

MeO

N

N

Me

Cl

3e

O N

NO2

MeO

N

N

Me

Cl

3e

Page 26: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

26

1H NMR (400 MHz) spectra of 3f

8 7 6 5 4 3 2 1 0 ppm

2.494

3.521

3.531

3.538

3.548

3.568

3.585

3.629

3.650

3.666

3.687

3.732

3.751

3.775

3.794

3.926

4.047

4.066

4.084

4.102

7.056

7.147

7.411

7.431

7.564

7.584

3.000

1.902

1.081

1.111

3.037

1.218

0.958

1.049

2.054

2.173

13C NMR (100 MHz) spectra of 3f

200 180 160 140 120 100 80 60 40 20 0 ppm

11.6

33.7

36.2

38.8

44.1

76.8

77.1

77.4

111.3

118.6

127.6

128.3

129.2

130.5

132.6

142.3

147.3

155.6

172.2

188.9

O N

NO2

MeO

N

N

Me

CN

3f

O N

NO2

MeO

N

N

Me

CN

3f

Page 27: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

27

1H NMR (400 MHz) spectra of 3g

7 6 5 4 3 2 1 0 ppm

2.471

3.465

3.473

3.481

3.491

3.501

3.517

3.533

3.593

3.615

3.630

3.651

3.664

3.688

3.707

3.744

3.914

3.954

3.973

3.991

6.766

6.787

7.014

7.123

7.166

7.187

3.000

2.014

2.140

2.965

4.029

1.999

0.985

3.067

13C NMR (100 MHz) spectra of 3g

200 180 160 140 120 100 80 60 40 20 0 ppm

11.7

34.4

36.1

38.2

44.7

55.2

76.8

77.1

77.4

114.0

127.2

128.3

129.2

130.4

133.8

142.8

155.4

158.5

173.3

190.0

O N

NO2

MeO

N

N

Me

OMe

3g

O N

NO2

MeO

N

N

Me

OMe

3g

Page 28: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

28

1H NMR (400 MHz) spectra of 3h

8 7 6 5 4 3 2 1 0 ppm

2.271

2.474

3.472

3.490

3.494

3.509

3.526

3.537

3.555

3.594

3.615

3.630

3.651

3.666

3.690

3.708

3.913

3.944

3.963

3.982

7.010

7.047

7.067

7.122

7.140

7.160

3.000

2.962

1.981

1.994

2.893

0.978

0.922

1.958

2.904

13C NMR (100 MHz) spectra of 3h

200 180 160 140 120 100 80 60 40 20 0 ppm

11.7

21.1

34.3

36.2

38.5

44.6

76.8

77.1

77.4

127.1

127.2

129.2

129.4

130.4

136.8

138.8

142.8

155.4

173.3

190.0

O N

NO2

MeO

N

N

Me

Me

3h

O N

NO2

MeO

N

N

Me

Me

3h

Page 29: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

29

1H NMR (400 MHz) spectra of 3i

8 7 6 5 4 3 2 1 0 ppm

2.412

3.608

3.627

3.645

3.664

3.683

3.708

3.727

3.752

3.769

3.772

3.793

3.810

3.829

3.851

4.977

6.990

7.129

7.393

7.412

7.431

7.466

7.485

7.522

7.532

7.540

7.549

7.557

7.709

7.729

7.815

3.006

7.044

0.990

0.986

1.008

4.010

1.013

1.005

1.000

13C NMR (100 MHz) spectra of 3i

200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm

11.6

32.8

33.7

36.1

44.5

76.8

77.1

77.4

122.6

123.5

125.5

125.7

126.5

127.3

127.8

129.0

129.3

130.5

131.1

133.9

138.1

142.7

155.4

173.0

190.0

O N

NO2

MeO

N

N

Me 3i

O N

NO2

MeO

N

N

Me 3i

Page 30: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

30

1H NMR (400 MHz) spectra of 3j

8 7 6 5 4 3 2 1 0 ppm

2.501

3.544

3.550

3.562

3.567

3.587

3.604

3.652

3.673

3.688

3.708

3.725

3.750

3.768

3.946

4.298

4.315

4.334

4.353

4.370

6.849

6.858

6.870

7.040

7.109

7.112

7.121

7.125

7.136

2.945

1.992

2.053

3.000

1.008

1.973

0.981

1.943

13C NMR (100 MHz) spectra of 3j

200 180 160 140 120 100 80 60 40 20 0 ppm

11.7

34.2

35.1

36.2

45.4

76.8

77.1

77.4

124.1

124.5

126.8

127.4

129.3

130.6

142.6

145.2

155.5

172.6

189.3

O N

NO2

MeO

N

N

Me

S

3j

O N

NO2

MeO

N

N

Me

S

3j

Page 31: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

31

1H NMR (400 MHz) spectra of 3k

8 7 6 5 4 3 2 1 0 ppm

2.520

3.465

3.483

3.508

3.526

3.541

3.562

3.578

3.643

3.664

3.671

3.680

3.689

3.700

3.715

3.732

3.969

4.063

4.081

4.099

4.117

4.135

4.144

6.054

6.062

6.216

6.221

6.223

6.228

7.050

7.138

7.286

7.289

3.000

2.046

2.029

2.972

1.002

0.964

0.970

0.982

0.991

1.094

13C NMR (100 MHz) spectra of 3k

200 180 160 140 120 100 80 60 40 20 0 ppm

11.7

31.9

32.5

36.2

42.1

76.8

77.1

77.4

106.0

110.2

127.3

129.3

130.5

141.9

142.6

154.6

155.5

172.7

189.4

O N

NO2

MeO

N

N

Me

O

3k

O N

NO2

MeO

N

N

Me

O

3k

Page 32: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

32

1H NMR (400 MHz) spectra of 3l

7 6 5 4 3 2 1 0 ppm

1.088

1.105

2.551

2.786

2.804

2.821

2.838

3.124

3.141

3.166

3.185

3.204

3.222

3.241

3.265

3.281

3.301

3.317

3.997

7.053

7.133

3.023

3.200

1.082

4.042

3.000

0.986

0.951

13C NMR (100 MHz) spectra of 3l

200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm

11.7

20.3

28.6

33.9

36.3

45.2

76.8

77.1

77.4

127.2

129.0

130.4

142.9

155.6

174.0

191.0

O N

NO2

MeO

N

N

Me

Me

3l

O N

NO2

MeO

N

N

Me

Me

3l

Page 33: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

33

1H NMR (400 MHz) spectra of 3m

7 6 5 4 3 2 1 0 ppm

1.114

1.132

1.149

2.486

3.355

3.369

3.385

3.399

3.407

3.422

3.461

3.478

3.495

3.511

3.526

3.584

3.602

3.620

3.641

3.661

3.917

4.051

4.069

4.086

4.104

6.994

7.079

3.049

3.000

3.061

1.905

2.943

2.016

0.968

0.910

13C NMR (100 MHz) spectra of 3m

200 180 160 140 120 100 80 60 40 20 0 ppm

10.6

12.9

28.1

35.2

36.8

39.0

60.4

75.7

76.0

76.3

126.3

128.2

129.4

141.2

154.6

171.5

171.6

188.0

O N

NO2

MeO

N

N

Me

COOEt

3m

O N

NO2

MeO

N

N

Me

COOEt

3m

Page 34: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

34

1H NMR (400 MHz) spectra of 3n

8 7 6 5 4 3 2 1 0 ppm

2.499

3.254

3.272

3.291

3.309

3.449

3.458

3.470

3.478

3.508

3.528

3.538

3.579

3.598

3.633

3.645

3.670

3.682

7.214

7.231

7.238

7.242

7.251

7.255

7.269

7.289

7.452

7.457

7.466

7.470

3.000

1.003

1.983

1.974

4.273

3.199

13C NMR (100 MHz) spectra of 3n

O N

NO2

MeCF3O

N

N

Ph3n

O N

NO2

MeCF3O

N

N

Ph3n

Page 35: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

35

19F NMR (376.4 MHz) spectra of 3n

-200-180-160-140-120-100-80-60-40-200 ppm

-71.740

O N

NO2

MeCF3O

N

N

Ph3n

Page 36: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

36

1H NMR (400 MHz) spectra of 3o

7 6 5 4 3 2 1 0 ppm

1.344

1.360

1.376

1.392

2.469

3.502

3.519

3.539

3.555

3.572

3.597

3.615

3.627

3.649

3.664

3.677

3.686

3.695

3.719

3.737

3.963

3.981

4.000

4.020

4.038

5.358

5.375

5.391

5.408

5.425

5.441

5.458

7.158

7.176

7.181

7.189

7.197

7.226

6.202

3.000

4.100

1.026

1.022

2.111

5.336

13C NMR (100 MHz) spectra of 3o

200 180 160 140 120 100 80 60 40 20 0 ppm

11.6

23.4

23.6

34.3

39.0

45.1

49.2

76.8

77.1

77.4

121.4

127.2

127.3

128.7

129.7

130.4

141.8

142.0

155.4

173.2

190.1

O N

NO2

MeO

N

N

i-Pr 3o

O N

NO2

MeO

N

N

i-Pr 3o

Page 37: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

37

1H NMR (400 MHz) spectra of 3p

8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm

2.448

3.445

3.462

3.481

3.499

3.541

3.561

3.584

3.603

3.616

3.637

3.653

3.674

3.682

3.699

3.725

3.742

3.906

3.924

3.943

3.961

3.980

7.105

7.110

7.125

7.152

7.169

7.184

7.189

7.199

7.205

7.222

7.236

7.251

7.257

3.000

0.992

3.047

1.037

9.148

3.024

13C NMR (100 MHz) spectra of 3p

200 180 160 140 120 100 80 60 40 20 0 ppm

11.7

34.2

38.8

44.7

76.8

77.1

77.4

125.8

127.3

127.4

128.7

128.8

129.0

129.7

130.4

138.1

141.8

142.7

155.4

173.1

188.5

O N

NO2

MeO

N

N

Ph 3p

O N

NO2

MeO

N

N

Ph 3p

Page 38: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

38

1H NMR (400 MHz) spectra of 4a

7 6 5 4 3 2 1 0 ppm3.567

3.585

3.604

3.622

3.642

3.660

3.681

3.697

3.717

3.733

3.759

3.776

3.912

4.027

4.045

4.064

4.083

4.098

7.012

7.138

7.183

7.200

7.217

7.257

7.264

7.276

7.294

7.315

4.245

3.000

1.151

1.042

0.983

1.113

4.364

5.205

13C NMR (100 MHz) spectra of 4a

200 180 160 140 120 100 80 60 40 20 0 ppm

34.5

36.2

38.9

44.4

76.8

77.1

77.4

125.8

127.3

128.5

128.8

129.2

129.8

130.7

141.8

142.8

157.6

173.8

189.9

O N

NO2

O

N

N

Me4a

O N

NO2

O

N

N

Me4a

Page 39: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

39

1H NMR (400 MHz) spectra of 4b

8 7 6 5 4 3 2 1 0 ppm

3.569

3.586

3.592

3.606

3.623

3.636

3.659

3.680

3.696

3.716

3.733

3.758

3.776

3.903

4.018

4.037

4.055

4.074

4.092

7.012

7.120

7.125

7.141

7.163

7.195

7.212

7.251

7.270

7.288

7.309

7.512

7.525

7.533

4.174

3.000

1.102

0.986

3.995

4.202

2.089

13C NMR (100 MHz) spectra of 4b

2030405060708090100110120130140150160170180190 ppm

34.5

36.2

38.9

44.5

76.8

77.1

77.4

115.6

115.8

121.9

121.9

127.3

127.3

128.8

129.2

129.7

131.4

131.5

141.8

142.7

156.7

162.9

165.4

174.1

189.8

O N

NO2

O

N

N

Me

F

4b

O N

NO2

O

N

N

Me

F

4b

Page 40: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

40

19F NMR (376.4 MHz) spectra of 4b

-85 -90 -95 -100 -105 -110 -115 ppm

-109.152

O N

NO2

O

N

N

Me

F

4b

Page 41: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

41

1H NMR (400 MHz) spectra of 4c

8 7 6 5 4 3 2 1 0 ppm

3.568

3.586

3.592

3.605

3.623

3.635

3.658

3.679

3.696

3.711

3.716

3.728

3.754

3.771

3.899

4.015

4.033

4.052

4.071

4.088

4.160

7.009

7.131

7.177

7.193

7.205

7.210

7.249

7.269

7.286

7.306

7.414

7.436

7.461

4.083

3.000

1.037

0.940

0.929

1.028

4.175

4.046

13C NMR (100 MHz) spectra of 4c

200 180 160 140 120 100 80 60 40 20 0 ppm

34.5

36.2

38.9

44.5

76.8

77.1

77.4

124.3

127.3

127.4

127.6

128.8

129.2

129.7

130.7

137.0

141.7

142.7

156.7

174.2

189.8

O N

NO2

O

N

N

Me

Cl

4c

O N

NO2

O

N

N

Me

Cl

4c

Page 42: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

42

1H NMR (400 MHz) spectra of 4d

8 7 6 5 4 3 2 1 0 ppm

3.547

3.565

3.584

3.602

3.627

3.636

3.645

3.657

3.673

3.694

3.709

3.727

3.752

3.769

3.840

3.896

4.018

4.037

4.055

4.073

4.092

6.948

6.969

7.002

7.128

7.173

7.191

7.208

7.249

7.268

7.287

7.294

7.312

7.475

7.497

4.144

3.000

3.077

1.084

3.012

0.952

1.063

4.253

2.087

13C NMR (100 MHz) spectra of 4d

200 180 160 140 120 100 80 60 40 20 0 ppm

34.5

36.2

38.9

44.4

55.4

76.8

77.1

77.4

113.9

117.9

127.3

127.3

128.8

129.2

129.8

130.8

141.9

142.7

157.2

161.5

173.8

189.9

O N

NO2

O

N

N

Me

OMe

4d

O N

NO2

O

N

N

Me

OMe

4d

Page 43: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

43

1H NMR (400 MHz) spectra of 4e

8 7 6 5 4 3 2 1 0 ppm

2.385

3.558

3.576

3.595

3.612

3.633

3.649

3.669

3.685

3.706

3.711

3.728

3.754

3.771

3.898

4.023

4.041

4.060

4.078

4.096

7.003

7.130

7.176

7.193

7.210

7.252

7.271

7.291

7.295

7.313

7.317

7.338

7.357

3.115

4.198

3.058

1.074

1.000

1.025

1.051

8.277

13C NMR (100 MHz) spectra of 4e

2030405060708090100110120130140150160170180190 ppm

21.4

34.5

36.2

38.9

44.4

125.7

126.3

127.3

128.4

128.8

129.2

129.7

129.8

131.4

138.3

141.8

142.8

157.7

173.7

189.9

O N

NO2

O

N

N

Me

Me

4e

O N

NO2

O

N

N

Me

Me

4e

Page 44: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

44

1H NMR (400 MHz) spectra of 4f

8 7 6 5 4 3 2 1 0 ppm

3.548

3.566

3.585

3.602

3.623

3.637

3.642

3.658

3.674

3.681

3.697

3.724

3.741

3.748

3.894

4.008

4.027

4.045

4.064

4.082

7.001

7.123

7.131

7.141

7.143

7.153

7.175

7.192

7.204

7.209

7.213

7.249

7.269

7.287

7.307

7.312

4.149

3.000

1.042

1.053

3.053

4.101

0.965

0.964

13C NMR (100 MHz) spectra of 4f

200 180 160 140 120 100 80 60 40 20 0 ppm

34.6

36.2

38.9

44.5

76.8

77.1

77.4

125.6

127.3

127.3

127.8

128.8

129.2

129.4

129.9

131.8

141.8

142.7

151.7

174.5

189.8

O N

NO2

O

N

N

Me

S

4f

O N

NO2

O

N

N

Me

S

4f

Page 45: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

45

1H NMR (400 MHz) spectra of 5a

7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm

2.483

2.719

2.738

2.759

2.767

2.778

2.785

2.807

2.825

3.493

3.511

3.530

3.547

3.594

3.603

3.614

3.630

3.651

3.741

3.760

3.779

3.798

3.817

7.189

7.207

7.209

7.216

7.233

7.263

3.000

2.018

1.051

3.995

1.017

2.988

2.062

13C NMR (100 MHz) spectra of 5a

200 180 160 140 120 100 80 60 40 20 0 ppm

11.6

33.8

39.9

40.3

51.9

76.8

77.1

77.4

127.0

127.5

128.9

130.4

141.1

155.5

171.6

172.8

O N

NO2

O

MeOMe

5a

O N

NO2

O

MeOMe

5a

Page 46: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

46

1H NMR (400 MHz) spectra of 6a

1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm

2.640

2.660

2.678

2.699

2.736

2.754

2.775

2.793

3.438

3.454

3.480

3.497

3.567

3.614

3.633

3.657

3.676

3.828

3.847

3.865

3.883

3.914

6.995

7.120

7.156

7.173

7.185

7.189

7.246

7.265

7.283

1.953

1.000

3.036

1.133

4.206

1.046

2.139

4.253

13C NMR (100 MHz) spectra of 6a

200 180 160 140 120 100 80 60 40 20 0 ppm

36.2

37.2

41.0

44.8

51.6

76.7

77.1

77.4

126.7

126.9

127.5

128.5

128.7

143.2

172.3

190.4

6a

COOMeO

N

N

Me

6a

COOMeO

N

N

Me

Page 47: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

47

VI Chiral HPLC trace analysisRacemic 3a

Chiral 3a:

HPLC traces of racemic 3a and chiral 3a. Area integration = 95% ee.

O N

NO2

MeO

N

N

Me 3a

O N

NO2

MeO

N

N

Me 3a

Page 48: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

48

Chiral 3a’:

HPLC traces of racemic 3a and chiral 3a’. Area integration = 95% ee.

O N

NO2

MeO

N

N

Me 3a'

Page 49: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

49

Racemic 3b

Chiral 3b:

HPLC traces of racemic 3b and chiral 3b. Area integration = 97% ee.

O N

NO2

MeO

N

N

Me

Br

3b

O N

NO2

MeO

N

N

Me

Br

Page 50: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

50

Racemic 3c

Chiral 3c:

HPLC traces of racemic 3c and chiral 3c. Area integration = 95% ee.

O N

NO2

MeO

N

N

Me

Br

3c

O N

NO2

MeO

N

N

Me

Br

3c

Page 51: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

51

Racemic 3d

Chiral 3d:

HPLC traces of racemic 3d and chiral 3d. Area integration = 96% ee.

O N

NO2

MeO

N

N

Me

Br

3d

O N

NO2

MeO

N

N

Me

Br

3d

Page 52: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

52

Racemic 3e

Chiral 3e:

HPLC traces of racemic 3e and chiral 3e. Area integration = 96% ee.

O N

NO2

MeO

N

N

Me

Cl

3e

O N

NO2

MeO

N

N

Me

Cl

3e

Page 53: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

53

Racemic 3f

Chiral 3f:

HPLC traces of racemic 3f and chiral 3f. Area integration = 92% ee.

O N

NO2

MeO

N

N

Me

CN

3f

O N

NO2

MeO

N

N

Me

CN

3f

Page 54: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

54

Racemic 3g

Chiral 3g:

HPLC traces of racemic 3g and chiral 3g. Area integration = 94% ee.

O N

NO2

MeO

N

N

Me

OMe

O N

NO2

MeO

N

N

Me

OMe

Page 55: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

55

Racemic 3h

Chiral 3h:

HPLC traces of racemic 3h and chiral 3h. Area integration = 94% ee.

O N

NO2

MeO

N

N

Me

Me

O N

NO2

MeO

N

N

Me

Me

Page 56: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

56

Racemic 3i

Chiral 3i:

HPLC traces of racemic 3i and chiral 3i. Area integration = 96% ee.

O N

NO2

MeO

N

N

Me 3i

O N

NO2

MeO

N

N

Me 3i

Page 57: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

57

Racemic 3j

Chiral 3j:

HPLC traces of racemic 3j and chiral 3j. Area integration = 95% ee.

O N

NO2

MeO

N

N

Me

S

3j

O N

NO2

MeO

N

N

Me

S

3j

Page 58: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

58

Racemic 3k

Chiral 3k:

HPLC traces of racemic 3k and chiral 3k. Area integration = 93% ee.

O N

NO2

MeO

N

N

Me

O

3k

O N

NO2

MeO

N

N

Me

O

3k

Page 59: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

59

Racemic 3l

Chiral 3l:

HPLC traces of racemic 3l and chiral 3l. Area integration = 94% ee.

O N

NO2

MeO

N

N

Me

Me

3l

O N

NO2

MeO

N

N

Me

Me

3l

Page 60: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

60

Racemic 3m

Chiral 3m:

HPLC traces of racemic 3m and chiral 3m. Area integration = 93% ee.

O N

NO2

MeO

N

N

Me

COOEt

3m

O N

NO2

MeO

N

N

Me

COOEt

3m

Page 61: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

61

Racemic 3n

Chiral 3n:

HPLC traces of racemic 3n and chiral 3n. Area integration = 97% ee.

O N

NO2

MeCF3O

N

N

Ph 3n

O N

NO2

MeCF3O

N

N

Ph 3n

Page 62: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

62

Racemic 3o

Chiral 3o:

HPLC traces of racemic 3o and chiral 3o. Area integration = 92% ee.

O N

NO2

MeO

N

N

i-Pr 3o

O N

NO2

MeO

N

N

i-Pr 3o

Page 63: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

63

Racemic 3p

Chiral 3p:

HPLC traces of racemic 3p and chiral 3p. Area integration = 95% ee.

O N

NO2

MeO

N

N

Ph 3p

O N

NO2

MeO

N

N

Ph 3p

Page 64: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

64

Racemic 4a

Chiral 4a:

HPLC traces of racemic 4a and chiral 4a. Area integration = 90% ee.

O N

NO2

O

N

N

Me 4a

O N

NO2

O

N

N

Me 4a

Page 65: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

65

Racemic 4b

Chiral 4b:

HPLC traces of racemic 4b and chiral 4b. Area integration = 95% ee.

O N

NO2

O

N

N

Me

F

4b

O N

NO2

O

N

N

Me

F

4b

Page 66: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

66

Racemic 4c

Chiral 4c:

HPLC traces of racemic 4c and chiral 4c. Area integration = 95% ee.

O N

NO2

O

N

N

Me

Cl

4c

O N

NO2

O

N

N

Me

Cl

4c

Page 67: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

67

Racemic 4d

Chiral 4d:

HPLC traces of racemic 4d and chiral 4d. Area integration = 95% ee.

O N

NO2

O

N

N

Me

OMe

4d

O N

NO2

O

N

N

Me

OMe

4d

Page 68: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

68

Racemic 4e

Chiral 4e:

HPLC traces of racemic 4e and chiral 4e. Area integration = 95% ee.

O N

NO2

O

N

N

Me

Me

4e

O N

NO2

O

N

N

Me

Me

4e

Page 69: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

69

Racemic 4f

Chiral 4f:

HPLC traces of racemic 4f and chiral 4f. Area integration = 95% ee.

O N

NO2

O

N

N

Me

S

4f

O N

NO2

O

N

N

Me

S

4f

Page 70: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

70

Racemic 5a

Chiral 5a:

HPLC traces of racemic 5a and chiral 5a. Area integration = 95% ee.

O N

NO2

O

MeOMe

5a

O N

NO2

O

MeOMe

5a

Page 71: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

71

Racemic 6a

Chiral 6a:

HPLC traces of racemic 6a and chiral 6a. Area integration = 90% ee.

6a

COOMeO

N

N

Me

6a

COOMeO

N

N

Me

Page 72: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

72

VII. Single Crystal X-Ray Diffraction of 4f

Table 1. Crystal data and structure refinement for 4f.

CCDC 1903727.

Table 1. Crystal data and structure refinement for 4f.

Identification code compound-4fEmpirical formula C21H18N4O4S

Formula weight 422.45

Temperature (K) 127(2)

Wavelength (Å) 1.54184

Crystal system orthorhombic

Space group P212121

Unit cell dimensions (Å, °) a = 6.0211(2) = 90

b = 16.1241(5) = 90

c = 20.6340(5) = 90

Volume (Å) 2003.25(10)

Z 4

Calculated density (g cm-3) 1.401

Absorption coefficient (mm-1) 1.753

F000 880

Crystal size (mm3) 0.6 0.4 0.3

range for data collection () 3.479 to 67.079

Miller index ranges -7 h 7, -16 k 19, -23 l 24

Reflections collected 16910

Independent reflections 3543 [Rint = 0.0657]

Completeness to max (%) 0.987

Max. and min. transmission 0.3203 and 0.7521

Refinement method Full-matrix least-squares on F2

Data / restraints / parameters 3543 / 15 / 272

Page 73: Supporting Information Derivatives Synthesis Addition of ... · General procedure for catalytic asymmetric synthesis of isoxazole analogues. O N O 2 N Me R 2 R 1 O N N R + O N NO

73

Goodness-of-fit on F2 1.064

Final R indices [I2(I)] R1 = 0.0916, wR2 = 0.2275

R indices (all data) R1 = 0.1040, wR2 = 0.2394

Largest diff. peak and hole (e Å-3) 1.320 and -0.460

Absolute structure parameter .018(13)